Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation

Mol Med Rep. 2023 May;27(5):103. doi: 10.3892/mmr.2023.12990. Epub 2023 Mar 31.

Abstract

Advanced glycation end products (AGEs) in lens proteins increase with aging, thus inducing cataracts and/or presbyopia. Hesperetin (Hst), which is an abundant plant flavanone largely derived from citrus species, and its derivatives attenuate cataracts and presbyopia in vivo and in vitro; however, no reports have described its effects on AGE formation in lens proteins. The present study demonstrated that AGEs in lens proteins increase with age in mice. Additionally, it showed that Hst can prevent AGEs and N(ε)‑carboxymethyl‑lysine generation and modification of lens proteins using in vitro in human lens epithelial cell lines and ex vivo in mouse lens organ cultures. Furthermore, treatment with Hst prevented lens hardening and decreased chaperone activity in lens proteins. These results suggested that Hst and its derivatives are good candidates for the prevention of presbyopia and cataracts.

Keywords: advanced glycation end product; hesperetin; lens protein; natural flavonoid; presbyopia.

MeSH terms

  • Animals
  • Cataract* / drug therapy
  • Cataract* / metabolism
  • Crystallins*
  • Glycation End Products, Advanced / metabolism
  • Humans
  • Maillard Reaction
  • Mice
  • Presbyopia*

Substances

  • hesperetin
  • Crystallins
  • Glycation End Products, Advanced

Grants and funding

The present study was supported by a grant from the Japan Society for the Promotion of Science KAKENHI (grant no. 20K07184) to YN and from the Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research.